120 related articles for article (PubMed ID: 9495845)
1. Pentobarbital antagonism of morphine analgesia mediated by spinal cholecystokinin.
Rady JJ; Lin W; Fujimoto JM
J Pharmacol Exp Ther; 1998 Mar; 284(3):878-85. PubMed ID: 9495845
[TBL] [Abstract][Full Text] [Related]
2. Antianalgesic action of dynorphin A mediated by spinal cholecystokinin.
Rady JJ; Holmes BB; Fujimoto JM
Proc Soc Exp Biol Med; 1999 Mar; 220(3):178-83. PubMed ID: 10193446
[TBL] [Abstract][Full Text] [Related]
3. Supraspinal neurotensin-induced antianalgesia in mice is mediated by spinal cholecystokinin.
Holmes BB; Rady JJ; Smith DJ; Fujimoto JM
Jpn J Pharmacol; 1999 Feb; 79(2):141-9. PubMed ID: 10202849
[TBL] [Abstract][Full Text] [Related]
4. Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia.
Rady JJ; Holmes BB; Tseng LF; Fujimoto JM
J Pharmacol Exp Ther; 2001 May; 297(2):582-9. PubMed ID: 11303046
[TBL] [Abstract][Full Text] [Related]
5. Pentobarbital administered intracerebroventricularly antagonizes morphine-induced antinociception in mice.
Wang FS; Fujimoto JM
J Pharmacol Exp Ther; 1993 Jun; 265(3):1361-8. PubMed ID: 8099619
[TBL] [Abstract][Full Text] [Related]
6. Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse.
Suh HW; Kim YH; Choi YS; Song DK
Peptides; 1995; 16(7):1229-34. PubMed ID: 8545243
[TBL] [Abstract][Full Text] [Related]
7. Systemic single dose morphine pretreatment desensitizes mice to the spinal antianalgesic action of dynorphin A (1-17).
Fujimoto JM; Holmes B
J Pharmacol Exp Ther; 1990 Jul; 254(1):1-7. PubMed ID: 1973192
[TBL] [Abstract][Full Text] [Related]
8. Elimination of the antianalgesic action of dynorphin A by spinal transsection in barbital-anesthetized mice.
Wang FS; Rady JJ; Fujimoto JM
J Pharmacol Exp Ther; 1994 Feb; 268(2):873-80. PubMed ID: 7906735
[TBL] [Abstract][Full Text] [Related]
9. Antianalgesia: stereoselective action of dextro-morphine over levo-morphine on glia in the mouse spinal cord.
Wu HE; Thompson J; Sun HS; Terashvili M; Tseng LF
J Pharmacol Exp Ther; 2005 Sep; 314(3):1101-8. PubMed ID: 15901793
[TBL] [Abstract][Full Text] [Related]
10. Involvement of supraspinal and spinal CCK receptors in the modulation of antinociception induced by cold water swimming stress in the mouse.
Suh HW; Song DK; Kwon SH; Kim KW; Min BH; Kim YH
Neuropeptides; 1996 Aug; 30(4):379-84. PubMed ID: 8914865
[TBL] [Abstract][Full Text] [Related]
11. [Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety].
Izumi T
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):463-73. PubMed ID: 9846276
[TBL] [Abstract][Full Text] [Related]
12. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
Kellstein DE; Mayer DJ
Brain Res; 1990 May; 516(2):263-70. PubMed ID: 2364292
[TBL] [Abstract][Full Text] [Related]
13. Confluence of antianalgesic action of diverse agents through brain interleukin(1beta) in mice.
Rady JJ; Fujimoto JM
J Pharmacol Exp Ther; 2001 Nov; 299(2):659-65. PubMed ID: 11602679
[TBL] [Abstract][Full Text] [Related]
14. Antianalgesic action of nociceptin originating in the brain is mediated by spinal prostaglandin E(2) in mice.
Rady JJ; Campbell WB; Fujimoto JM
J Pharmacol Exp Ther; 2001 Jan; 296(1):7-14. PubMed ID: 11123356
[TBL] [Abstract][Full Text] [Related]
15. Naloxone and norbinaltorphimine administered intracerebroventricularly antagonize spinal morphine-induced antinociception in mice through the antianalgesic action of spinal dynorphin A (1-17).
Holmes BB; Fujimoto JM
J Pharmacol Exp Ther; 1992 Apr; 261(1):146-53. PubMed ID: 1348537
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat.
Yamamoto T; Sakashita Y
Anesthesiology; 1999 May; 90(5):1382-91. PubMed ID: 10319787
[TBL] [Abstract][Full Text] [Related]
17. Spinal and supraspinal mechanisms for morphine-pentobarbital antinociceptive interaction in relation to cardiac acceleration response in rats.
Jebeles JA; Kissin I; Bradley EL
Anesth Analg; 1986 Jun; 65(6):601-4. PubMed ID: 3754702
[TBL] [Abstract][Full Text] [Related]
18. Supraspinal flumazenil inhibits the antianalgesic action of spinal dynorphin A (1-17).
Rady JJ; Holmes BB; Fujimoto JM
Pharmacol Biochem Behav; 1998 May; 60(1):245-54. PubMed ID: 9610949
[TBL] [Abstract][Full Text] [Related]
19. Increased spinal cholecystokinin activity after systemic resiniferatoxin: electrophysiological and in situ hybridization studies.
Broberger C; Farkas-Szallasi T; Szallasi A; Lundberg JM; Hökfelt T; Wiesenfeld-Hallin Z; Xu XJ
Pain; 2000 Jan; 84(1):21-28. PubMed ID: 10601669
[TBL] [Abstract][Full Text] [Related]
20. Enterostatin (APGPR) suppresses the analgesic activity of morphine by a CCK-dependent mechanism.
Takenaka Y; Shimano T; Yamada Y; Yoshida M; Ohinata K; Yoshikawa M
Peptides; 2008 Apr; 29(4):559-63. PubMed ID: 18304696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
